Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for preventing and treating malignant tumors and production technology

A malignant tumor and drug technology, applied in the field of medicine, can solve problems such as inaccurate curative effect and large side effects, and achieve the effects of inhibiting proliferation and division, prolonging survival period, and weakening the degree of malignancy

Inactive Publication Date: 2019-03-19
荣华
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of the tumor traditional Chinese medicines currently used clinically have shortcomings such as inaccurate curative effect and large side effects. Therefore, it is of great significance to research and develop drugs with significant curative effect, safety and no side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for preventing and treating malignant tumors and production technology
  • Medicine for preventing and treating malignant tumors and production technology
  • Medicine for preventing and treating malignant tumors and production technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The medicine for the prevention and treatment of malignant tumors in this embodiment is made from the following raw materials: 10g verdigris, 45g Tieluohua, 155g Scutellaria baicalensis, 195g Fritillaria japonicus, 210g sea clam shells, 105g bellflower, 52g mint, 165g forsythia, 198g honeysuckle, 105g of peach kernels, 120g of Sichuan Achyranthes bidentata, 52g of rhubarb, 170g of Scrophulariae, 140g of Adenophora, 20g of Cordyceps sinensis, 192g of tortoise shell.

[0048] The production process of the medicine of the present embodiment comprises the following steps:

[0049] 1) Pulverize verdigris, Tieluohua, Cordyceps sinensis, and tortoise shell into fine powder, sieve, mix well and set aside;

[0050] 2) The rest of the raw materials are boiled with water. Among them, the scutellaria baicalensis, Fritillaria, sea clam shells, platycodon, forsythia, honeysuckle, Achyranthes bidentata, rhubarb, scrophulariaceae, and northern sand ginseng are added first, followed by ...

Embodiment 2

[0052] The medicine for the prevention and treatment of malignant tumors in this embodiment is made from the following raw materials: 12g of aeruginosa, 48g of Tieluohua, 150g of Scutellaria baicalensis, 200g of Fritillaria japonicus, 200g of sea clam shells, 120g of platycodon grandiflorum, 50g of peppermint, 150g of forsythia, 200g of honeysuckle, 120g of peach kernel, 120g of Achyranthes sichuanensis, 50g of rhubarb, 150g of Scrophulariae, 150g of Adenophora, 15g of Cordyceps sinensis, 200g of tortoise shell.

[0053] The production process of the medicine of the present embodiment comprises the following steps:

[0054] 1) Pulverize verdigris, Tieluohua, Cordyceps sinensis, and tortoise shell into fine powder, sieve, mix well and set aside;

[0055] 2) The rest of the raw materials are boiled with water. Among them, the scutellaria baicalensis, Fritillaria, sea clam shells, platycodon, forsythia, honeysuckle, Achyranthes bidentata, rhubarb, scrophulariaceae, and northern s...

Embodiment 3

[0057] The medicine for the prevention and treatment of malignant tumors in this embodiment is made from the following raw materials: 16g of aeruginosa, 40g of Tieluohua, 140g of Scutellaria baicalensis, 205g of Fritillaria japonicus, 190g of sea clam shells, 110g of Platycodon grandiflorum, 60g of peppermint, 152g of forsythia, 180g of honeysuckle, 125g of peach kernel, 112g of Achyranthes sichuanensis, 45g of rhubarb, 142g of Scrophulariae, 155g of Adenophora, 10g of Cordyceps sinensis, 205g of tortoise shell.

[0058] The production process of the medicine of the present embodiment comprises the following steps:

[0059] 1) Pulverize verdigris, Tieluohua, Cordyceps sinensis, and tortoise shell into fine powder, sieve, mix well and set aside;

[0060] 2) The rest of the raw materials are boiled with water. Among them, the scutellaria baicalensis, Fritillaria, sea clam shells, platycodon, forsythia, honeysuckle, Achyranthes bidentata, rhubarb, scrophulariaceae, and northern s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the invention discloses a medicine for preventing and treating malignant tumors and a production technology and relates to the technical field of medicines. The medicine is preparedfrom the following raw materials in parts by weight: 10 to 18 parts of verdigris, 40 to 50 parts of melted iron, 140 to 160 parts of radix scutellariae, 180 to 215 parts of bulbus fritillariae thunbergii, 185 to 210 parts of sea clam shell, 105 to 130 parts of radix platycodon, 40 to 60 parts of herba menthae, 140 to 165 parts of fructus forsythiae, 180 to 220 parts of honeysuckle flower, 105 to 130 parts of peach kernel, 105 to 130 parts of radix cyathulae, 40 to 60 parts of radix et rhizoma rhei, 140 to 170 parts of radix scrophulariae, 140 to 160 parts of radix glehniae, 10 to 20 parts of caterpillar fungus and 180 to 220 parts of tortoise plastron. The medicine provided by the invention can be used for improving organism copper deficiency and cell oxygen deficiency conditions, activating the activity of enzymes needing copper and iron in cells, inhibiting the proliferation and division of tumor cells, weakening the malignant degree of the tumor cells, selectively directly killing the tumor cells and promoting the bone marrow hematopoiesis and the organism immunity; the medicine has the characteristics that the medicine can be used for improving the symptoms of clinical patients, alleviating pains, improving the life quality and prolonging the life cycle; and meanwhile, normal tissue cells are not injured while the tumor cells are killed.

Description

technical field [0001] The embodiments of the present invention relate to the technical field of medicines, in particular to a medicine and production process for preventing and treating malignant tumors. Background technique [0002] Tumor is a new organism formed by the body under the action of various carcinogenic factors when a certain cell in a local tissue loses its normal regulation of its growth at the gene level, resulting in abnormal clonal proliferation. It is generally believed that tumor cells are monoclonal, that is, all tumor cells in a tumor are descendants of a mutant cell. According to the cell characteristics of new organisms and the degree of harm to the body, tumors are divided into two categories: benign tumors and malignant tumors, and cancer is the general term for malignant tumors. [0003] With the development of the economy, the environmental pollution is becoming more and more serious, as well as the changes in human living habits, irregular life...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8966A61P35/00A61P35/02A61K35/618A61K35/586A61K33/34A61K33/26
CPCA61K33/26A61K33/34A61K35/586A61K35/618A61K36/068A61K36/21A61K36/23A61K36/346A61K36/355A61K36/534A61K36/539A61K36/634A61K36/708A61K36/736A61K36/808A61K36/8966A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61P35/00A61P35/02A61K2300/00
Inventor 何宏联荣华
Owner 荣华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com